Ultra-low temperature (ULT) freezers Market Key Players, Dynamics, Growth and Insights By 2024

1. Ultra-low temperature (ULT) freezers Market Key Players, Dynamics, Growth and Insights By 2024 Segmentation Analysis The global ultra-low temperature freezers market is segmented as type, end user, and region. Based on type, the global market is divided into upright ULT freezers and chest ULT freezers. The former can register a CAGR of 3.30% during the forecast period On the basis of end user, the global ultra-low temperature freezer market is segmented into bio-banks, hospitals and clinics, and academic & research institutes. The biobanks segment accounted for a market value of USD 341.89 million in 2018. It can register a CAGR of 3.40% during the assessment period due to donations by volunteers and accumulation of biological samples due to prevalence of chronic diseases. Hospitals & clinics were the second largest segment and touted to exhibit a CAGR of 3.29% during the forecast period. Ultra-low temperature (ULT) freezers are medical devices used for the storage of biological samples of blood, sperm, cells, etc. These freezers are extensively used in blood banks, biomedical engineering facilities, hospitals, research institutes, and epidemic prevention services. They have operating temperatures between the range of -45 and -86 degree Celsius. The global ultra-low temperature freezer market report by Market Research Future (MRFR) contains its importance in biobanking and its future prospects for thep period between 2019 to 2024. Competition Outlook Arctiko, VWR International, Global Cooling Inc, BINDER GmbH, Labcold, Helmer scientific, Stirling Ultracold, Eppendorf AG., Esco Micro Pte Ltd., PHC Corporation, Thermo Fisher Scientific Inc., and others are prime players of the ultra-low temperature freezer market. Market Outlook The global ultra-low temperature freezer market size is projected to reach USD 897.28 million by 2024. It can exhibit 3.20% CAGR from 2019 to 2024 (forecast period). Increased demand in blood banking storage and leaps in research and development are primary factors driving market growth. Expansion plans of pharmaceutical and biopharmaceutical companies in expanding its research can induce the demand for ULT freezers and refrigerators for storage of biological samples. The scope in drug discovery and a slew of clinical trials for furthering research in disease prevention can work in favor of the global ultra-low temperature freezer market. Surgeries requiring rare blood and tissues for implants can spur the market demand. According to the report by National Center for Biotechnology of 2016, close to 40,829 hematopoietic stem

2. cells transplant operations were performed across several European countries indicating the positive growth trajectory of the market during the forecast period. Request a Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1813 Regional Analysis The global ultra-low temperature freezers market, based on region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are expected to dominate the global market till 2024 due to large number of healthcare providers and demand for large storage solutions. Strides in biobanking and efforts by hospitals to lower energy consumption can bode well for the regional demand. The growth is facilitated by players such as Panasonic Healthcare which have launched freezers with high operational functions and low power consumption. The region can accrue revenues at 3.30% CAGR during the forecast period. Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/ultra-low-temperature-freezer- market-1813 Europe follows the Americas in ranking driven by measures taken by pharmaceutical companies for preservation of biological samples. Inclination towards bio banking and cord blood banking are expected to drive the regional demand exponentially. Europe had a valuation of USD 208.06 million in 2017. It can exhibit a CAGR of 3.14% during the forecast period. APAC, on the other hand, is expected to experience a robust growth rate due to investments in healthcare infrastructure and subsidies biopharmaceutical companies for drug development. Lastly, the MEA has limited growth owing to low awareness levels. provided to pharmaceutical and Browse More Healthcare Related Research Reports: Americas Respiratory Therapeutic Devices Market– Forecast to 2020 | MRFR Transradial Access Devices Market Research Report –Global Forecast to 2023| MRFR Drug Infusion System Market Research Report –Global Forecast to 2023| MRFR NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

3. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact: Akash Anand Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com